Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05438095 · ClinicalTrials.gov registry record
Medication Adherence in Patients With Sarcoidosis
A clinical trial of Medication Adherence and Sarcoidosis, sponsored by Johns Hopkins University.
- Active
- Registry status
- 150
- Enrollment target
- 2
- Study locations
NCT05438095 is a study of Medication Adherence and Sarcoidosis that is active but no longer recruiting, run by Johns Hopkins University. The registered enrollment target is 150 participants, below the 1,654-participant average among 52 other Medication Adherence trials with a reported enrollment target (91% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT05438095, a study of Medication Adherence and Sarcoidosis, is active but no longer recruiting, sponsored by Johns Hopkins University.
- ACTIVE NOT RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of the study is to look at the relationship between how individuals with Sarcoidosis take the sarcoidosis medicines and how it affects the disease, to evaluate any factors that may make individuals not want to take the medicines, and to develop and refine ways to help support individuals with Sarcoidosis especially when it comes to the medicines. The overall hypothesis is higher medication adherence will be associated with better clinical outcomes in sarcoidosis. The investigators will enroll 150 patients with biopsy proven pulmonary sarcoidosis for at least one year who are on any oral treatment regimen for at least six months into a 12-month longitudinal study.
Conditions Studied
Study Locations (2)
Maryland
- Johns Hopkins Bayview Asthma and Allergy Center - Baltimore
- Johns Hopkins Greenspring Station - Timonium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2022-05-11 |
| Est. Completion | 2026-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05438095
The ClinicalTrials.gov registry entry for NCT05438095 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,654-participant average among 52 other Medication Adherence trials with a reported enrollment target (91% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Medication Adherence appearing as the primary indexed condition, and to 0 interventions.
NCT05438095 reports 2 study locations spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT05438095 about?
NCT05438095 is a clinical study titled "Medication Adherence in Patients With Sarcoidosis". The goal of the study is to look at the relationship between how individuals with Sarcoidosis take the sarcoidosis medicines and how it affects the disease, to evaluate any factors that may make individuals not want to take the medicines, and to develop and refine ways to help support individuals wi...
What is the current status of trial NCT05438095?
This trial is currently active not recruiting. The enrollment target is 150 participants. The study started on 2022-05-11. Estimated completion is 2026-08-31.
What conditions does trial NCT05438095 study?
This clinical trial studies the following conditions: Medication Adherence, Sarcoidosis.
Who is sponsoring clinical trial NCT05438095?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05438095 being conducted?
This trial has 2 study locations across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Medication Adherence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Mobile Gaming App to Improve Adherence to PrEP
RECRUITING · NA
-
1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV
RECRUITING · NA
-
Medication Adherence Program
RECRUITING · NA
-
An Integrated Intervention Using a Pill Ingestible Sensor System
RECRUITING · Phase 2
-
Improving Medication Adherence Using Family-focused and Literacy-sensitive Strategies
RECRUITING · NA
-
Refinement and Testing of Recruitment Methodology for Behavioral Medication Adherence Interventions Using Behavioral Science-based Approaches
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.